Researchers from the National Institute on Drug Abuse, National Institutes of Health and Case Western Reserve University School of Medicine used a target trial emulation framework to evaluate the comparative effectiveness of the new use of semaglutide versus the new use of 7 other anti-diabetes medications, including other GLP-1RAs, on TUD-related health care measures in 3 study populations: patients with comorbid type 2 diabetes and TUD, patients with comorbid type 2 diabetes and TUD who had a diagnosis of obesity, and those who did not have a diagnosis of obesity
Loss of magel2, a candidate gene for features of Prader-Willi syndrome, impairs reproductive function in mice
[DOI] [PMC free article] [PubMed] [Google Scholar] 16.DellOlio A., Scott W.T., Jr., Taroncher-Ferrer S., San Onofre N., Soriano J.M., Rubert J
No heavy fillers or unnecessary thickeners designed to bulk up the texture
The FDA approved Ozempic to treat type 2 diabetes, and it is sometimes used off-label to help with weight loss
In 2023 the FDA placed CJC-1295 in "Category 2" of its interim 503A bulks list, meaning it identified significant safety concerns and did not permit its use in traditional pharmacy compounding
